BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CIITA, P33076, 4261, ENSG00000179583, MHC2TA, C2TA
38 results:

  • 1. Stealth transgenes enable CAR-T cells to evade host immune responses.
    Grauwet K; Berger T; Kann MC; Silva H; Larson R; Leick MB; Bailey SR; Bouffard AA; Millar D; Gallagher K; Turtle CJ; Frigault MJ; Maus MV
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38724463
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape.
    Mangolini M; Maiques-Diaz A; Charalampopoulou S; Gerhard-Hartmann E; Bloehdorn J; Moore A; Giachetti G; Lu J; Roamio Franklin VN; Chilamakuri CSR; Moutsopoulos I; Rosenwald A; Stilgenbauer S; Zenz T; Mohorianu I; D'Santos C; Deaglio S; Hodson DJ; Martin-Subero JI; Ringshausen I
    Nat Commun; 2022 Oct; 13(1):6220. PubMed ID: 36266281
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses.
    Chan KL; Gomez J; Cardinez C; Kumari N; Sparbier CE; Lam EYN; Yeung MM; Garciaz S; Kuzich JA; Ong DM; Brown FC; Chan YC; Vassiliadis D; Wainwright EN; Motazedian A; Gillespie A; Fennell KA; Lai J; House IG; Macpherson L; Ang CS; Dawson SJ; Beavis PA; Wei AH; Burr ML; Dawson MA
    Cancer Cell; 2022 Oct; 40(10):1190-1206.e9. PubMed ID: 36179686
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Transcriptional Plasticity Drives leukemia Immune Escape.
    Eagle K; Harada T; Kalfon J; Perez MW; Heshmati Y; Ewers J; Koren JV; Dempster JM; Kugener G; Paralkar VR; Lin CY; Dharia NV; Stegmaier K; Orkin SH; Pimkin M
    Blood Cancer Discov; 2022 Sep; 3(5):394-409. PubMed ID: 35709529
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Expression dynamics of the immune mediators ARG1, TBET, ciita, IL10 and TGFB1 in chronic myeloid leukaemia patients during the first year of imatinib therapy.
    Toloza MJ; Bestach Y; Lincango-Yupanki M; Bordone J; Mariano R; Tarqui M; Pérez M; Aranguren PN; Enrico A; Larripa IB; Belli CB
    Gene; 2022 Mar; 813():146110. PubMed ID: 34902507
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models.
    Forlani G; Shallak M; Accolla RS; Romanelli MG
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360767
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immunogenomic Landscape of Hematological Malignancies.
    Dufva O; Pölönen P; Brück O; Keränen MAI; Klievink J; Mehtonen J; Huuhtanen J; Kumar A; Malani D; Siitonen S; Kankainen M; Ghimire B; Lahtela J; Mattila P; Vähä-Koskela M; Wennerberg K; Granberg K; Leivonen SK; Meriranta L; Heckman C; Leppä S; Nykter M; Lohi O; Heinäniemi M; Mustjoki S
    Cancer Cell; 2020 Sep; 38(3):380-399.e13. PubMed ID: 32649887
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Restriction factors in human retrovirus infections and the unprecedented case of ciita as link of intrinsic and adaptive immunity against HTLV-1.
    Forlani G; Shallak M; Ramia E; Tedeschi A; Accolla RS
    Retrovirology; 2019 Nov; 16(1):34. PubMed ID: 31783769
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma.
    Xie M; Huang X; Ye X; Qian W
    Int Immunopharmacol; 2019 Dec; 77():105999. PubMed ID: 31704289
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation.
    Toffalori C; Zito L; Gambacorta V; Riba M; Oliveira G; Bucci G; Barcella M; Spinelli O; Greco R; Crucitti L; Cieri N; Noviello M; Manfredi F; Montaldo E; Ostuni R; Naldini MM; Gentner B; Waterhouse M; Zeiser R; Finke J; Hanoun M; Beelen DW; Gojo I; Luznik L; Onozawa M; Teshima T; Devillier R; Blaise D; Halkes CJM; Griffioen M; Carrabba MG; Bernardi M; Peccatori J; Barlassina C; Stupka E; Lazarevic D; Tonon G; Rambaldi A; Cittaro D; Bonini C; Fleischhauer K; Ciceri F; Vago L
    Nat Med; 2019 Apr; 25(4):603-611. PubMed ID: 30911134
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A caspase-2-RFXANK interaction and its implication for MHC class II expression.
    Forsberg J; Li X; Akpinar B; Salvatori R; Ott M; Zhivotovsky B; Olsson M
    Cell Death Dis; 2018 Jan; 9(2):80. PubMed ID: 29362422
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression.
    Tarafdar A; Hopcroft LE; Gallipoli P; Pellicano F; Cassels J; Hair A; Korfi K; Jørgensen HG; Vetrie D; Holyoake TL; Michie AM
    Blood; 2017 Jan; 129(2):199-208. PubMed ID: 27793879
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies.
    Van Roosbroeck K; Ferreiro JF; Tousseyn T; van der Krogt JA; Michaux L; Pienkowska-Grela B; Theate I; De Paepe P; Dierickx D; Doyen C; Put N; Cools J; Vandenberghe P; Wlodarska I
    Genes Chromosomes Cancer; 2016 May; 55(5):428-41. PubMed ID: 26850007
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Major Histocompatibility Complex Class II Transactivator ciita Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.
    Forlani G; Abdallah R; Accolla RS; Tosi G
    J Virol; 2016 Jan; 90(7):3708-21. PubMed ID: 26792751
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.
    Brown PJ; Wong KK; Felce SL; Lyne L; Spearman H; Soilleux EJ; Pedersen LM; Møller MB; Green TM; Gascoyne DM; Banham AH
    Leukemia; 2016 Mar; 30(3):605-16. PubMed ID: 26500140
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling.
    Yuan J; Wright G; Rosenwald A; Steidl C; Gascoyne RD; Connors JM; Mottok A; Weisenburger DD; Greiner TC; Fu K; Smith L; Rimsza LM; Jaffe ES; Campo E; Martinez A; Delabie J; Braziel RM; Cook JR; Ott G; Vose JM; Staudt LM; Chan WC;
    Am J Surg Pathol; 2015 Oct; 39(10):1322-30. PubMed ID: 26135560
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Epigenetic modification and preliminary investigation of the mechanism of the immune evasion of HL-60 cells.
    Liu JH; Bian YM; Xie Y; Lu DP
    Mol Med Rep; 2015 Jul; 12(1):1059-65. PubMed ID: 25815463
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation.
    Green MR; Kihira S; Liu CL; Nair RV; Salari R; Gentles AJ; Irish J; Stehr H; Vicente-Dueñas C; Romero-Camarero I; Sanchez-Garcia I; Plevritis SK; Arber DA; Batzoglou S; Levy R; Alizadeh AA
    Proc Natl Acad Sci U S A; 2015 Mar; 112(10):E1116-25. PubMed ID: 25713363
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The biophysical and biochemical properties of the autoimmune regulator (AIRE) protein.
    Perniola R; Musco G
    Biochim Biophys Acta; 2014 Feb; 1842(2):326-37. PubMed ID: 24275490
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Unraveling the complexity of hepatitis B virus: from molecular understanding to therapeutic strategy in 50 years.
    Liu B; Wen X; Huang C; Wei Y
    Int J Biochem Cell Biol; 2013 Sep; 45(9):1987-96. PubMed ID: 23819994
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.